当前位置: X-MOL 学术J. Biomed. Mater. Res. Part B Appl. Biomater. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The clinical use of bone graft substitutes in orthopedic surgery in Germany—A 10-years survey from 2008 to 2018 of 1,090,167 surgical interventions
Journal of Biomedical Materials Research Part B: Applied Biomaterials ( IF 3.4 ) Pub Date : 2021-07-22 , DOI: 10.1002/jbm.b.34911
Markus Rupp 1 , Lisa Klute 1 , Susanne Baertl 1 , Nike Walter 1 , Gopala-Krishna Mannala 1 , Leona Frank 1 , Christian Pfeifer 1 , Volker Alt 1 , Maximilian Kerschbaum 1
Affiliation  

Aim of the study was to evaluate (1) the overall use of bone graft substitutes, autografts and allografts, (2) of different types of bone graft substitutes (calcium sulfate, calcium phosphate, calcium phosphate ceramics or polymethyl methacrylate) and of different bone grafts (cancellous vs. cortical), and (3) the use of antibiotic-loading of bone graft substitutes in orthopedic surgery in Germany. Gross data were provided from the Federal Statistical Office of Germany and revealed an overall increase in bone defect reconstruction procedures using bone graft substitutes, autografts and allografts from 86,294 in 2008 to 99,863 cases in 2018 (+15.7%). The relative use of bone graft substitutes for these interventions strongly increased from 11.8% in 2008 (10,163 cases) to 23.9% in 2018 (23,838 cases) with an increase of +134.4%. Furthermore, antibiotic-loaded bone graft substitutes were implanted more frequently with an overall increase of +194% (2008: n = 2,657; 2018: n = 7,811). The work shows an increasing use of bone graft substitutes and antibiotic-loaded bone graft substitutes over the last 10 years in Germany.

中文翻译:

德国骨移植替代物在骨科手术中的临床应用——2008 年至 2018 年 1,090,167 次手术干预的 10 年调查

本研究的目的是评估 (1) 骨移植替代物、自体移植物和同种异体移植物的总体使用情况,(2) 不同类型的骨移植替代物(硫酸钙、磷酸钙、磷酸钙陶瓷或聚甲基丙烯酸甲酯)和不同骨移植物(松质与皮质),以及(3)在德国的骨科手术中使用抗生素负载的骨移植替代物。德国联邦统计局提供的总数据显示,使用骨移植替代物、自体移植物和同种异体移植物的骨缺损重建程序总体增加,从 2008 年的 86,294 例增加到 2018 年的 99,863 例(+15.7%)。在这些干预措施中,骨移植替代品的相对使用率从 2008 年的 11.8%(10,163 例)大幅增加至 2018 年的 23.9%(23,838 例),增幅为 +134.4%。此外,n  = 2,657;2018 年:n  = 7,811)。这项工作表明,在过去的 10 年中,德国越来越多地使用骨移植替代品和载有抗生素的骨移植替代品。
更新日期:2021-07-22
down
wechat
bug